Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 6, 2020 · 10-Q · 37 days after period end · 0001564590-20-037768
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$2.92M | -$3.62M | -$2.79M | -$169.00K |
| EPS Diluted | -$1.68 | -$10.08 | -$1.82 | -$79.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 6, 2020 · 37 d after period end
